Uterine perforation at the time of brachytherapy for carcinoma of the cervix

By Irvin W.   Rice L.   Taylor P.   Andersen W.   Schneider B.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 113-122

Elsevier

Access to resources Recommend Favorite

Is HDR Brachytherapy for Carcinoma of the Uterine Cervix High-Throughput But High Risk?

By Fowler Jack F.  

Acta Oncologica, Vol. 37, Iss. 2, 1998-05 ,pp. : 113-115

Informa Healthcare

Access to resources Recommend Favorite

Multimodality Therapy in Early-Stage Neuroendocrine Carcinoma of the Uterine Cervix

By Boruta D.M.   Schorge J.O.   Duska L.A.   Crum C.P.   Castrillon D.H.   Sheets E.E.  

Gynecologic Oncology, Vol. 81, Iss. 1, 2001-04 ,pp. : 82-87

Elsevier

Access to resources Recommend Favorite

Application of Tumor Markers CEA, TPA, and SCC-Ag in Patients with Low-Risk FIGO Stage IB and IIA Squamous Cell Carcinoma of the Uterine Cervix

By Juang C.-M.   Wang P.-H.   Yen M.-S.   Lai C.-R.   Ng H.-T.   Yuan C.-C.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Microinvasive Carcinoma of the Uterine Cervix: Histological Findings on Cone Specimens Related to Residual Neoplasia on Hysterectomy

By Gurgel M.S.C.   Bedone A.J.   de Angelo Andrade L.A.L.   Panetta K.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 437-440

Elsevier

Access to resources Recommend Favorite